{"schema_version":"secwatch.filing_event.v1","accession":"0001438133-24-000158","form_type":"8-K","ticker":"TNDM","cik":"0001438133","company_name":"TANDEM DIABETES CARE INC","filed_at":"2024-06-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.428767+00:00","generated_at":"2026-06-01T03:51:56.624656+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Tandem and Dexcom amend agreements to integrate Sigi pump with G7 CGM for five years","bullets":["On May 22, 2024, Tandem and Dexcom entered into two amended and restated agreements.","The Development Agreement covers integration of Tandem's Sigi insulin pump with Dexcom's G7 CGM.","Both agreements extend the term to five years and amend definitions and commercial terms.","The Commercialization Agreement addresses the sale and support of the integrated systems.","Original agreements were signed November 2020; new deals update device scope and conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0001438133-24-000158","json":"https://secwatch.observer/filing/0001438133-24-000158.json","markdown":"https://secwatch.observer/filing/0001438133-24-000158.md","text":"https://secwatch.observer/filing/0001438133-24-000158.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1438133/000143813324000158/0001438133-24-000158-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1438133/000143813324000158/tndm-20240522.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T03:51:56.624656+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}